BRPI0509504A - compostos de tiadiazol-amina para o tratamento de distúrbios neurodegenerativos - Google Patents
compostos de tiadiazol-amina para o tratamento de distúrbios neurodegenerativosInfo
- Publication number
- BRPI0509504A BRPI0509504A BRPI0509504-2A BRPI0509504A BRPI0509504A BR PI0509504 A BRPI0509504 A BR PI0509504A BR PI0509504 A BRPI0509504 A BR PI0509504A BR PI0509504 A BRPI0509504 A BR PI0509504A
- Authority
- BR
- Brazil
- Prior art keywords
- treatment
- amine compounds
- neurodegenerative disorders
- compounds
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
- C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- C07D285/135—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
COMPOSTOS DE TIADIAZOL-AMINA PARA O TRATAMENTO DE DISTúRBIOS NEURODEGENERATIVOS. A presente invenção refere-se a compostos da fórmula 1 onde R1, R3, R5 R7, X, Y e U (elevados) são como definidos. Os compostos de fórmula 1 possuem atividade para inibir a produção do peptídio Ab. A invenção também refere-se a composições farmacêuticas e métodos para o tratamento de doenças e distúrbios, por exemplo, distúrbios neurodegenerativos e/ou neurológicos, exemplo, mal Alzheimer, em um mamífero compreendendo compostos de fórmula 1.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55877704P | 2004-04-01 | 2004-04-01 | |
PCT/IB2005/000801 WO2005095368A1 (en) | 2004-04-01 | 2005-03-23 | Thiadiazole-amine compounds for the treatment of neurodegenerative disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0509504A true BRPI0509504A (pt) | 2007-09-11 |
Family
ID=34962247
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0509504-2A BRPI0509504A (pt) | 2004-04-01 | 2005-03-23 | compostos de tiadiazol-amina para o tratamento de distúrbios neurodegenerativos |
Country Status (7)
Country | Link |
---|---|
US (1) | US7232820B2 (pt) |
EP (1) | EP1735294A1 (pt) |
JP (1) | JP2007530661A (pt) |
BR (1) | BRPI0509504A (pt) |
CA (1) | CA2561596A1 (pt) |
MX (1) | MXPA06011350A (pt) |
WO (1) | WO2005095368A1 (pt) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7763609B2 (en) | 2003-12-15 | 2010-07-27 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
KR100814599B1 (ko) * | 2004-03-23 | 2008-03-17 | 화이자 프로덕츠 인크. | 신경퇴행성 장애 치료용 이미다졸 화합물 |
MX2007004551A (es) * | 2004-10-18 | 2007-05-23 | Amgen Inc | Compuestos tiadiazol y metodos de uso. |
JP2009508934A (ja) * | 2005-09-22 | 2009-03-05 | ファイザー・プロダクツ・インク | 神経障害治療のためのイミダゾール化合物 |
GB0602335D0 (en) * | 2006-02-07 | 2006-03-15 | Remynd Nv | Thiadiazole Derivatives For The Treatment Of Neurodegenerative Diseases |
US8541406B2 (en) | 2006-02-07 | 2013-09-24 | Nv Remynd | Thiadiazole derivatives for the treatment of neurodegenerative diseases |
GB0623258D0 (en) | 2006-11-22 | 2007-01-03 | Remynd Nv | Thiadiazole derivatives for the treatment of neuro-degenerative diseases |
GB0704394D0 (en) * | 2007-03-07 | 2007-04-11 | Senexis Ltd | Compounds |
FR2913886B1 (fr) | 2007-03-22 | 2012-03-02 | Guerbet Sa | Utilisation de nanoparticules metalliques dans le diagnostique de la maladie d'alzheimer |
WO2009011871A2 (en) * | 2007-07-17 | 2009-01-22 | Amgen Inc. | Thiadiazole modulators of pkb |
EP2173728A2 (en) | 2007-07-17 | 2010-04-14 | Amgen Inc. | Heterocyclic modulators of pkb |
US8889670B2 (en) | 2009-02-18 | 2014-11-18 | Boehringer Ingelheim International Gmbh | Heterocyclic compounds which modulate the CB2 receptor |
US8299103B2 (en) * | 2009-06-15 | 2012-10-30 | Boehringer Ingelheim International Gmbh | Compounds which selectively modulate the CB2 receptor |
JP2013517271A (ja) | 2010-01-15 | 2013-05-16 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Cb2受容体を調節する化合物 |
US8846936B2 (en) | 2010-07-22 | 2014-09-30 | Boehringer Ingelheim International Gmbh | Sulfonyl compounds which modulate the CB2 receptor |
EP2803668A1 (en) | 2013-05-17 | 2014-11-19 | Boehringer Ingelheim International Gmbh | Novel (cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles |
KR20240056726A (ko) * | 2021-09-01 | 2024-04-30 | 스프링웍스 테라퓨틱스, 인크. | 니로가세스타트의 합성 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6114537A (en) | 1996-02-26 | 2000-09-05 | Apotex Inc. | Process for scavenging thiols |
US5962535A (en) * | 1997-01-17 | 1999-10-05 | Takeda Chemical Industries, Ltd. | Composition for alzheimer's disease |
AR039059A1 (es) | 2001-08-06 | 2005-02-09 | Sanofi Aventis | Compuesto derivado de acilaminotiazol, su utilizacion, procedimientos para prepararlo, composicion farmaceutica que lo comprende, y compuestos intermediarios |
CA2534532A1 (en) | 2003-08-21 | 2005-03-10 | Pfizer Products, Inc. | Compounds for the treatment of neurodegenerative disorders |
-
2005
- 2005-03-11 US US11/078,867 patent/US7232820B2/en not_active Expired - Fee Related
- 2005-03-23 CA CA002561596A patent/CA2561596A1/en not_active Abandoned
- 2005-03-23 WO PCT/IB2005/000801 patent/WO2005095368A1/en not_active Application Discontinuation
- 2005-03-23 EP EP05718290A patent/EP1735294A1/en not_active Withdrawn
- 2005-03-23 BR BRPI0509504-2A patent/BRPI0509504A/pt not_active IP Right Cessation
- 2005-03-23 MX MXPA06011350A patent/MXPA06011350A/es unknown
- 2005-03-23 JP JP2007505657A patent/JP2007530661A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
MXPA06011350A (es) | 2006-12-15 |
US7232820B2 (en) | 2007-06-19 |
WO2005095368A1 (en) | 2005-10-13 |
US20050222219A1 (en) | 2005-10-06 |
EP1735294A1 (en) | 2006-12-27 |
CA2561596A1 (en) | 2005-10-13 |
JP2007530661A (ja) | 2007-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0509504A (pt) | compostos de tiadiazol-amina para o tratamento de distúrbios neurodegenerativos | |
UA83899C2 (uk) | Сполуки імідазолу для лікування нейродегенеративних розладів | |
BR0314611A (pt) | Compostos de tiazol para o tratamento de distúrbios neurodegenerativos | |
BRPI0509477A (pt) | compostos de sulfonamida para o tratamento de distúrbios neurodegenerativos | |
BRPI0413245A (pt) | compostos heteroarila de 6 membros para o tratamento de distúrbio neurodegenerativos | |
BRPI0509515A (pt) | composto, formulação farmacêutica, uso de um composto método para tratamento de doenças, e, processo para a preparação de um composto | |
MXPA05012196A (es) | Compuestos de isoxazol e isotiazol para el tratamiento de trastornos neurodegenerativos. | |
UY28484A1 (es) | Compuestos para el tratamiento de trastornos neurodegenerativos | |
BRPI0509464A (pt) | compostos tiazol sulfonamida para o tratamento de distúrbios neurodegenerativos | |
ATE402150T1 (de) | Pyrazolaminverbindungen zur behandlung neurodegenerativer erkrankungen | |
RS20080139A (en) | Imidazole coumpounds for the treatment of neurological disorders | |
BRPI0509582A (pt) | compostos de tiazol-amina e respectivas composições farmacêuticas | |
UY28458A1 (es) | Compuestos de oxazol para el tratamiento de trastornos neurodegenerativos | |
BRPI0509386A (pt) | compostos de isoxazol- e isotiazol-amina para o tratamento de distúrbios neurodegenerativos | |
DOP2006000200A (es) | Compuestos de imidazol para el tratamiento de trastonos neurologicos | |
DOP2004000982A (es) | Compuestos para el tratamiento de trastornos neurodegenerativos | |
CU23591B7 (es) | Compuestos de imidazol para el tratamiento de desórdenes neurovegetativos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2137 DE 20/12/2011. |